IDEAYA Biosciences, Inc. (IDYA) stock forecast and price target
Price $31.83 · data as of November 13, 2026
12-month price target
Average target$50.69
Upside / downside+59.3%
Analysts13
ConsensusStrong buy
Low $30.00Average $50.69High $66.00
Gold marker: average target · white marker: today’s price ($31.83)
Analyst ratings
Strong buy 3Buy 12Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-4.77 | −272.8% | $42M |
| Next fiscal year ends December 31, 2027 | $-4.15 | +13.0% | $124M |
| Next quarter ends December 31, 2026 | $-1.16 | −23.3% | $20M |
| Quarter after ends March 31, 2027 | $-1.24 | −11.6% | $9M |
Consensus of the analysts covering IDEAYA Biosciences, updated daily. In the last 30 days 3 estimates were raised and 4 lowered.
Frequently asked questions
What is the IDEAYA Biosciences stock price target?
The average 12-month target from 13 analysts is $50.69, 59.3% above the current price of $31.83 Targets range from $30.00 to $66.00.
Is IDEAYA Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (3 strong buy, 12 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is IDEAYA Biosciences expected to earn?
Analysts expect EPS of $-4.77 for the fiscal year ending December 31, 2026 and $-4.15 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.